← Back to Clinical Trials
Recruiting NCT07229365

NCT07229365 Children's Viewing Behavior

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07229365
Status Recruiting
Phase
Sponsor SightGlass Vision, Inc.
Condition Myopia
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-12-22
Primary Completion 2026-12-30

Trial Parameters

Condition Myopia
Sponsor SightGlass Vision, Inc.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 7 Years
Max Age 14 Years
Start Date 2025-12-22
Completion 2026-12-30
Interventions
Novel spectacle lens designSpectacle lenses

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

Eligibility Criteria

Inclusion Criteria: A person is eligible for inclusion in the study if he/she: * Is 7-14 years of age, inclusive * Requires spherical spectacle lenses within the power range available for the study lenses * Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent * Is willing and able to follow instructions and maintain the appointment schedule * Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected * Has had a self-reported oculo-visual examination in the last two years * Spectacle cylinder of ≤ -0.75DC in both eyes Exclusion Criteria: A person will be excluded from the study if he/she: * Is unable to complete the necessary study activities * Has any systemic disease affecting ocular health * Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health * Is aphakic

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology